Showing all 4 results

  • Placeholder
    In Stock

    Teneligliptin & Metformin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.

    Active IngredientStrengthPrimary Clinical Function
    Teneligliptin Hydrobromide Hydrate INN20 mgImmediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control.
    Metformin Hydrochloride BP/Ph.Eur.500 mg (Sustained-Release)Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization.
    ExcipientsHypromellose (HPMC) / Microcrystalline Cellulose / Magnesium StearateSR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin)
  • Placeholder
    In Stock

    Teneligliptin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the active pharmaceutical ingredient across diverse tropical and high-humidity climates.

    Active IngredientStrengthPrimary Clinical Use
    Teneligliptin Hydrobromide Hydrate INN20 mgStandard Global Dose: Once-daily therapy for glycemic control in Type 2 Diabetes.
    ExcipientsMicrocrystalline Cellulose / Mannitol / Croscarmellose Sodium / Magnesium StearateDiluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid absorption)
  • Placeholder
    In Stock

    Vildagliptin & Metformin Tablets

    Free

    Product Composition & Strength

    We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.

    Active IngredientStrength & FormatPrimary Clinical Use
    Vildagliptin INN/Ph.Eur.50 mg (Immediate Release Layer)Rapid dissolution to block DPP-4 and manage post-prandial incretin levels.
    Metformin Hydrochloride USP/BP500 mg / 850 mg / 1000 mg (IR or SR)Provides continuous baseline hepatic glucose suppression and peripheral sensitization.
    ExcipientsHypromellose (HPMC) / Microcrystalline Cellulose / Titanium DioxideSR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release)
  • Placeholder
    In Stock

    Vildagliptin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed strictly in high-barrier Alu-Alu blister strips to guarantee absolute protection from moisture and environmental degradation.

    Active IngredientStrengthPrimary Clinical Use
    Vildagliptin INN/Ph.Eur.50 mgStandard Adult Dose for monotherapy or adjunctive combination therapy.
    ExcipientsMicrocrystalline Cellulose / Anhydrous Lactose / Magnesium StearateDiluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion)